The information on this page is intended for clinicians and hospitals to obtain COVID-19 Convalescent Plasma for their patients. If you are an individual who has recovered from a COVID-19 infection and wish to be a convalescent plasma donor, please visit our COVID-19 Convalescent Plasma Donor Information Page. Hospitals and clinicians should refer potential donors to this site as well. If you currently have or suspect that you have COVID-19 and have questions about your health, please contact your healthcare professional.
The American Red Cross has developed a process to identify and qualify individuals who have recovered from coronavirus disease 2019 (COVID-19) and to collect their COVID-19 convalescent plasma. The program works with clinicians to enable rapid access for qualifying patients.
The Red Cross is adjusting its labelling, distribution and ordering processes to accommodate the FDA’s Emergency Use Authorization (EUA) for COVID-19 convalescent plasma. For more information visit the AABB Toolkits: Overview of EUA for CCP and the COVID-19 Convalescent Plasma (CCP) under Emergency Use Authorization.
EUA Ordering for Red Cross Customers: Ordering may occur through the normal ordering pathways for product under this EUA, though high titer and low titer labelled units will not be distributed until late October. The Red Cross will communicate changes to hospital customers as information becomes available. All convalescent plasma orders for Red Cross customers will continue to be placed directly in Connect.
The Biomedical Advanced Research and Development Authority (BARDA) will be funding all units of COVID-19 convalescent plasma transfused under the EAP and EUA, so there will be no charge to hospitals operating under either. In line with our mission to prevent and alleviate human suffering in the face of emergencies, the Red Cross is committed to assisting with the plasma collections of carefully screened COVID-19-recovered donors necessary to help enable rapid access to this treatment.
Emergency Use Authorization
The FDA issued an emergency use authorization (EUA) for the transfusion of COVID-19 Convalescent Plasma to qualifying patients.
Please refer to the FDA website, the FDA Guidance, and the FDA EUA Fact Sheet for healthcare providers for further information.
Registration: Registration is not required.
Ordering Convalescent Plasma: Hospitals should contact their regular blood supplier for requests for COVID-19 Convalescent Plasma (CCP). For Red Cross customers, all convalescent plasma orders should be placed directly
We want to share with you that, through all of the above processes, we understand the urgency and that there are patients who are in need.
Thank you for all your efforts to help patients during this unprecedented time. The Red Cross looks forward to supporting you through participation in this program.
We look forward to working together with our hospital partners to support this new development in the fight against COVID-19.
Individuals who have fully recovered from coronavirus infection can learn how to be a convalescent plasma donor here .
Key Scientific Resources: